ROSEN, A LEADING LAW FIRM, Encourages CVRx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVRX
A securities class action lawsuit has been filed against CVRx, Inc. alleging the company made materially false and misleading statements about revenue growth, sales practices, regulatory compliance, and reimbursement strategy. The lawsuit claims CVRx generated revenue through improper sales practices, including improper marketing of Barostim, kickbacks, and false information to government health insurance programs. Investors who purchased CVRx common stock between July 25, 2023 and August 6, 2026 may be entitled to compensation. The lead plaintiff deadline is January 8, 2027.



